Sask. research lab says its COVID-19 vaccine shows positive results in Phase 1 trial

Clinical trials for the Vaccine and Infectious Disease Organization's COVAC-2 vaccine are yielding some positive results, according to the University of Saskatchewan, where VIDO is based. Interim data from Phase 1 clinical trials has demonstrated the vaccine ...